1.The First Study on Nucleotide-level Identification of Hb Koriyama in a Patient with Severe Hemolytic Anemia.
Seungman PARK ; Jun Eun PARK ; Sung Im CHO ; Yongbum JEON ; Sung Sup PARK ; Moon Woo SEONG
Annals of Laboratory Medicine 2012;32(1):99-101
Hereditary hemolytic anemia comprises a group of disorders in which red blood cells are destroyed faster than they are produced in the bone marrow; various hereditary factors can cause this condition, including production of defective Hb and erythrocyte membrane. Recently, we identified Hb Koriyama, a rare Hb variant that was undetectable in Hb electrophoresis and stability tests, in a patient with severe hemolytic anemia. This is the first study to show the nucleotide-level sequence variations in Hb Koriyama. On the basis of our results, we conclude that unstable Hb may not be detectable by conventional Hb electrophoresis or stability tests. Thus, we suggest further genetic workup in cases of unexplained hereditary hemolytic anemia.
Amino Acid Sequence
;
Anemia, Hemolytic/blood/*diagnosis
;
Child
;
Female
;
Gene Duplication
;
Hemoglobins, Abnormal/*genetics
;
Heterozygote
;
Humans
;
Molecular Sequence Data
;
Mutation
;
Sequence Analysis, DNA
2.First Korean Case of Robinsoniella peoriensis Bacteremia in a Patient with Aspiration Pneumonia.
Yongbum JEON ; Taek Soo KIM ; Hong Bin KIM ; Kyoung Un PARK ; Junghan SONG ; Eui Chong KIM
Annals of Laboratory Medicine 2012;32(5):370-374
Robinsoniella peoriensis has recently been identified as a Gram-positive, spore-forming, anaerobic rod originally recovered from swine manure storage pits. To date, 6 cases of R. peoriensis infection have been reported, including 2 cases of bacteremia, 1 of abdominal fluid collection, and 3 of wound infection. In the present study, we report a 76-yr-old man with R. peoriensis bacteremia who developed aspiration pneumonia. Gram staining of a purified colony revealed Gram-positive, rod-shaped bacteria. Biochemical identification using API 20 A (bioMerieux, France) indicated presence of Clostridium spp. We performed both 500-bp and full-gene sequencing of 16S rRNA of the isolate. The sequence was analyzed with MicroSeq ID 16S rRNA Library v2.0 (Applied Biosystems, USA), GenBank Basic Local Alignment Search Tool (BLAST) (http://www.ncbi.nlm.nih.gov/genbank), and EzTaxon database v2.1 (http://www.eztaxon.org). The 500-bp 16S rRNA sequence of the blood culture isolate showed 99.16-99.79% similarity with R. peoriensis and the full-gene 16S rRNA sequence showed 98.87-99.50% similarity with R. peoriensis. The organism was confirmed as R. peoriensis by using all of the mentioned databases except for MicroSeq, which did not include the RNA sequence of this bacterium. This case suggests that identification of R. peoriensis might be challenging in clinical laboratories with no access to molecular methods, as certain commercial identification systems may not identify, or may misidentify, this organism. To the best of our knowledge, this is the first report of the isolation of R. peoriensis in Korea.
Aged
;
Bacteremia/*microbiology
;
Clostridium/classification/genetics/*isolation & purification
;
Databases, Genetic
;
Humans
;
Male
;
Phylogeny
;
Pneumonia, Aspiration/*diagnosis/microbiology
;
RNA, Ribosomal, 16S/chemistry/genetics
;
Republic of Korea
;
Sequence Analysis, DNA
3.Performance Evaluation of the CAPILLARYS 2 FLEX Piercing Analyzer for HbA1c Determination.
Yongbum JEON ; Minje HAN ; Kyunghoon LEE ; Ho Eun CHANG ; Kyoung Un PARK ; Junghan SONG
Laboratory Medicine Online 2013;3(4):221-226
BACKGROUND: The hemoglobin A1c (HbA1c) level is widely used to monitor glycemic control in diabetes mellitus patients, and various methods are used for its determination. The CAPILLARYS 2 FLEX Piercing (Sebia) is a fully automated, high-throughput glycohemoglobin (HbA1c) analyzer based on capillary electrophoresis. METHODS: The analytical performance of the CAPILLARYS 2 FLEX Piercing analyzer was evaluated for its precision, linearity, correlation with the Variant II Turbo (Bio-Rad Laboratories, Inc.) analyzer, and its vulnerability to interference by carbamylated hemoglobin. We also investigated its agreement with National Glycohemoglobin Standardization Program (NGSP) targets. All evaluations were performed according to CLSI guidelines EP05, EP06, and EP09. RESULTS: The coefficients of variation (CVs) for within-run and total imprecision were 1.7% and 1.8% at low concentrations and 1.2% and 1.3% at high concentrations, respectively. Linearity was excellent, with R2=0.9882 in the range of 5.13-13.83%; these results highly correlated with those produced by Variant II Turbo (R2=0.9978). The 95% confidence interval (for differences from the NGSP target) was -0.3618-0.3343%. No significant interference of carbamylated hemoglobin was noted. CONCLUSIONS: The CAPILLARYS 2 FLEX Piercing analyzer showed excellent precision and linearity. Its results correlated with those obtained by the Variant II Turbo analyzer, and were agreement with the NGSP target. Therefore, its analytical performance is satisfactory for diabetes diagnosis and treatment monitoring.
Capillaries
;
Diabetes Mellitus
;
Electrophoresis, Capillary
;
Hemoglobins
;
Humans
;
Organothiophosphorus Compounds
4.Evaluation of a Fully Automated, Rapid Detection System for CYP2C19 and UGT1A1 Genotyping.
Yongbum JEON ; Seung Jun LEE ; Sung Im CHO ; Soo Hyun SEO ; Eun Kyung RA ; Seungman PARK ; Moon Woo SEONG ; Sung Sup PARK
Journal of Laboratory Medicine and Quality Assurance 2014;36(2):92-98
BACKGROUND: The need for genotyping single nucleotide polymorphisms (SNPs) in genes encoding drug-metabolizing enzymes is increasing. Therefore, the recent focus has been on developing fully automated methods for the rapid and accurate measurement of SNPs. METHODS: We used the quenching probe (QP) method and i-densy IS-5310 to genotype 200 DNA specimens from 200 healthy Koreans and 100 whole blood from another 100 for the SNPs CYP2C19*2 and CYP2C19*3. We also performed genotyping of UGT1A1*6 and UGT1A1*28 with the above mentioned 200 DNA samples and 81 whole blood samples. The results of the assay were then compared to conventional direct sequencing. RESULTS: The allele frequencies of CYP2C19 were 25.7% for *2 and 10.3% for *3, and those of UGT1A1 were 17.3% for *6 and 11.2% for *28. These results are similar to those reported in previous studies on Korean populations. The CYP2C19 and UGT1A1 genotypes determined by the QP method perfectly matched (100.0%, K=1.000, P<0.001 for CYP2C19, and 99.6%, K=0.992, P<0.001 for UGT1A1) those determined by direct sequencing, barring a single exception for the UGT1A1 genotype in 1 DNA specimen. CONCLUSIONS: Our results suggest that the QP method, owing to its speed and ease of use, will enable rapid and sensitive diagnosis in clinical laboratories.
Diagnosis
;
DNA
;
Gene Frequency
;
Genotype
;
Polymorphism, Single Nucleotide
5.Identification of Two Novel NPM1 Mutations in Patients with Acute Myeloid Leukemia.
Yongbum JEON ; Sang Won SEO ; Seonyang PARK ; Seungman PARK ; So Yeon KIM ; Eun Kyung RA ; Sung Sup PARK ; Moon Woo SEONG
Annals of Laboratory Medicine 2013;33(1):60-64
BACKGROUND: Genetic abnormalities in adult AML are caused most frequently by somatic mutations in exon 12 of the NPM1 gene, which is observed in approximately 35% of AML patients and up to 60% of patients with cytogenetically normal AML (CN-AML). METHODS: We performed mutational analysis, including fragment analysis and direct sequencing of exon 12 of the NPM1 gene, on 83 AML patients to characterize the NPM1 mutations completely. RESULTS: In this study, NPM1 mutations were identified in 19 (22.9%) of the 83 AML patients and in 12 (42.9%) of the 28 CN-AML patients. Among the 19 patients with NPM1 mutations, type A NPM1 mutations were identified in 16 (84.2%) patients, whereas non-A type NPM1 mutations were observed in 3 (15.8%) patients. Two of the 3 non-A type NPM1 mutations were novel: c.867_868insAAAC and c.869_873indelCTTTAGCCC. These 2 novel mutant proteins display a nuclear export signal motif (L-xxx-L-xx-V-x-L) less frequently and exhibit a mutation at tryptophan 290 that disrupts the nucleolar localization signal. CONCLUSIONS: This study suggests that novel NPM1 mutations may be non-rare and that supplementary sequence analysis is needed along with conventional targeted mutational analysis to detect non-A types of NPM1 mutations.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Amino Acid Motifs
;
Base Sequence
;
DNA Mutational Analysis
;
Exons
;
Female
;
Humans
;
Leukemia, Myeloid, Acute/*genetics/pathology
;
Male
;
Middle Aged
;
Mutation
;
Nuclear Proteins/*genetics
;
Young Adult
6.Quantification of Human Plasma-Busulfan Concentration by Liquid Chromatography-Tandem Mass Spectrometry.
Soo Young MOON ; Min Kyoo LIM ; Susie HONG ; Yongbum JEON ; Minje HAN ; Sang Hoon SONG ; Kyoung Soo LIM ; Kyung Sang YU ; In Jin JANG ; Ji Won LEE ; Hyoung Jin KANG ; Junghan SONG
Annals of Laboratory Medicine 2014;34(1):7-14
BACKGROUND: Busulfan, an alkylating agent administered prior to hematopoietic stem cell transplantation, has a narrow therapeutic range and wide variability in metabolism. We developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for rapid and accurate quantification of plasma busulfan. METHODS: Busulfan was separated and detected using an LC system containing a C18 column equipped with MS/MS. The sample was eluted with a mobile phase gradient for a total run time of 10 min. Plasma busulfan concentration was quantified against a 6-point standard curve in a multiple reaction monitoring mode at mass-to-charge (m/z) 264.1 > 151.1. Precision, recovery, matrix effect, linearity, detection capability, carryover, and stability were evaluated. The range of plasma busulfan concentration was obtained by analyzing samples from 9 children receiving busulfan. RESULTS: The coefficients of variation of within-run and within-laboratory precision were all below 5%. Recoveries were all within the range of 100-105%. Linearity was verified from 0 to 5,000 ng/mL. Limit of detection and limit of quantification were 1.56 and 25 ng/mL, respectively. Carryover rate was within allowable limits. Plasma busulfan concentration was stable for 2 weeks at -20degrees C and -80degrees C, but decreased by 25% when the plasma was stored for 24 hr at room temperature, and by <5% in 24 hr at 4degrees C. The plasma busulfan concentrations were between 347 ng/mL and 5,076 ng/mL. CONCLUSIONS: Our method using LC-MS/MS enables highly accurate, reproducible, and rapid busulfan monitoring with minimal sample preparation. The method may also enable safe and proper dosage.
Busulfan/*blood/standards
;
Child
;
Child, Preschool
;
*Chromatography, High Pressure Liquid/standards
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Infant
;
Quality Control
;
Reference Standards
;
*Tandem Mass Spectrometry/standards